dextrothyroxine has been researched along with Bigfoot Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dilu, NJ; Sokolo, R | 1 |
| Stingl, P | 1 |
| Cartel, JL; Martin, PM; Moulia-Pelat, JP; Nguyen, L; Roux, JF; Spiegel, A | 1 |
1 trial(s) available for dextrothyroxine and Bigfoot Disease
| Article | Year |
|---|---|
[Comparative efficacy of annual and semi-annual doses of ivermectin or diethylcarbamazine for the prevention of lymphatic filariasis].
Topics: Adolescent; Adult; Animals; Diethylcarbamazine; Dose-Response Relationship, Drug; Double-Blind Method; Elephantiasis; Humans; Ivermectin; Male; Middle Aged; Wuchereria bancrofti | 1992 |
2 other study(ies) available for dextrothyroxine and Bigfoot Disease
| Article | Year |
|---|---|
[A text-book case of tropical facial elephantiasis].
Topics: Adult; Antifungal Agents; Elephantiasis; Elephantiasis, Filarial; Face; Fatal Outcome; Filaricides; Humans; Ivermectin; Ketoconazole; Male; Superinfection; Zygomycosis | 2007 |
[Elephantiasis soon eliminated? New therapeutic concepts make mass treatment possible].
Topics: Albendazole; Diethylcarbamazine; Drug Administration Schedule; Elephantiasis; Filaricides; Humans; Ivermectin | 2000 |